A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

Clinical trial NCT06550713 · RECRUITING

Trial details

NCT number: NCT06550713
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2019-10-22
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.